Skip to main content
Fig. 3 | Journal of Cardiothoracic Surgery

Fig. 3

From: Impact of remote monitoring in heart failure patients with cardiac implantable electronic devices during COVID-19 pandemic: a single center experience

Fig. 3

Comparison of NT-proBNP levels (A) and change in NYHA functional class (B) at baseline and hospital admissions for worsening heart failure in the remote monitoring (RMG) and conventionally followed (CFG) patient groups. Patients in the conventionally followed group (CFG) had a significantly increased N terminal-proBNP (brain natriuretic peptide) levels at worsening heart failure event related hospital admissions (15,529 ± 362 pg/ml in CFG vs. 9762 ± 168 pg/ml in the RMG; p = 0.01 >) and more pronounced deterioration from baseline NYHA functional class than patients in remote monitoring group (RMG) (mean ∆NYHA in CFG: 1.32 vs. mean ∆NYHA in RMG:0.65; p = 0.026)

Back to article page